STI Window Periods: When Testing After Exposure Works

If you had a possible STI exposure, the most common question is simple: when will a test actually work? The answer is the "window period" — the time between exposure and when a test can reliably detect an infection. Testing before that window closes is one of the most common reasons for a false negative result.

This guide explains what STI window periods are, how they differ by infection, and how to think about timing when you plan a test. It is educational only and is not a substitute for individualized medical advice, diagnosis, or treatment. If you already have symptoms, or you know you were exposed to a specific infection, talk to a clinician — do not wait for a window period to close before seeking care.

If you're trying to decide what to do right now after a possible exposure (post-exposure prophylaxis, emergency contraception, symptom triage, etc.), start with our decision guide: What to do after unprotected sex. This page is the timing reference you can come back to when you're ready to schedule the actual test.

What is an STI window period?

An STI window period is the time between when a person is exposed to an infection and when a specific test can detect that infection with reasonable accuracy (per CDC). It is a property of the test, not of the person — different tests for the same infection can have different window periods because they look for different things (the pathogen's genetic material, an antigen it produces, or the antibodies your immune system makes in response).

Because tests need something detectable to find, testing during the window period can return a negative result even if an infection is present. That result is not "wrong" in a laboratory sense — the test simply ran before there was enough of the target to detect. This is why timing matters as much as choosing the right test.

A negative result taken after the appropriate window period is generally reliable for that specific test and that specific exposure (per CDC), but no test rules out infection with 100% certainty in every case. Clinicians will factor in your exposure, symptoms, and risk profile when interpreting a result.

Window period vs. incubation period

These two terms are often used interchangeably, but they mean different things:

• Incubation period is the time between exposure and when symptoms may appear (per Cleveland Clinic).
• Window period is the time between exposure and when a test can detect the infection (per CDC).

They usually do not line up. Many STIs are asymptomatic — chlamydia and gonorrhea often cause no symptoms at all (per CDC) — so waiting for symptoms is not a reliable way to decide when to test. On the other hand, some infections can cause symptoms before the antibody-based test can pick them up, which is why a clinician-ordered NAAT (nucleic acid amplification test) may be used earlier when symptoms are present.

The practical takeaway: use window periods, not symptoms, to plan when to test after a possible exposure.

Approximate window periods by infection

The ranges below are approximate and reflect commonly cited guidance from the CDC, ASHA, and MedlinePlus. Your clinician may recommend earlier or later testing based on your specific situation, the test being used, and your exposure history. These are not personalized recommendations.

HIV

• Fourth-generation antigen/antibody blood test (Ag/Ab): typically detects HIV about 18 to 45 days after exposure (per CDC).
• Antibody-only tests can take up to 90 days to turn positive (per CDC).
• Nucleic acid tests (NAT) — usually reserved for high-risk exposures or acute symptoms — can detect HIV as early as 10 to 33 days after exposure (per CDC).

Because of this range, the CDC recommends confirmatory or repeat testing at three months after exposure when the initial test is negative but exposure risk is high (per CDC). If you may have had a high-risk exposure in the last 72 hours, post-exposure prophylaxis (PEP) is time-sensitive — that is a clinical decision, not a testing decision, and should be discussed with a clinician immediately (per CDC).

Chlamydia

Chlamydia is detected with a NAAT on a urine sample or a swab. The commonly cited window period is approximately 7 to 14 days after exposure (per CDC and ASHA). Because chlamydia is frequently asymptomatic (per CDC), timing the test correctly is often more important than waiting for symptoms.

Gonorrhea

Gonorrhea is also detected by NAAT. The typical window period is approximately 7 to 14 days after exposure (per CDC). Like chlamydia, it can be asymptomatic — especially in throat or rectal infections (per CDC) — so at-site testing may be recommended by a clinician if there was oral or anal exposure.

Syphilis

Syphilis is detected with blood-based antibody tests (a treponemal or non-treponemal assay). The window period is typically 3 to 6 weeks after exposure, and in some cases up to 90 days (per CDC). Because the first sign of syphilis (a painless sore called a chancre) can appear before antibodies are detectable, anyone who notices a new sore in the genital, anal, or oral area should see a clinician rather than wait for a blood test window to close (per CDC).

Trichomoniasis

Trichomoniasis is detected with a NAAT (usually on a urine sample or vaginal swab). The commonly cited window period is approximately 7 to 28 days after exposure (per CDC). Trichomoniasis is one of the most common curable STIs in the U.S. but is often asymptomatic, especially in men (per CDC), so testing is often the only way to identify it.

Hepatitis B

The window period for the hepatitis B surface antigen (HBsAg) blood test is approximately 3 to 9 weeks after exposure, though antibodies to the surface antigen (anti-HBs) may take longer (per CDC). The CDC recommends specific post-exposure prophylaxis protocols after a known exposure — that is a clinical decision and should be discussed with a clinician (per CDC).

Hepatitis C

Hepatitis C antibody tests typically detect infection 8 to 11 weeks after exposure, and can take up to 6 months in some cases (per CDC). A separate HCV RNA test can detect the virus itself earlier, sometimes within 1 to 2 weeks, and is used in specific clinical situations (per CDC).

HSV-1 / HSV-2 (herpes)

Herpes is a special case. Two things to understand:

1. Antibody blood testing has limited usefulness for asymptomatic screening. The CDC does not recommend routine type-specific HSV serologic screening of the general asymptomatic population because of accuracy concerns and the risk of false positives (per CDC).
2. When testing is used for someone with symptoms, a direct swab of the lesion with a NAAT is more accurate than a blood test. If a blood antibody test is used, seroconversion typically takes 2 to 12 weeks, and in some cases up to 16 weeks (per CDC and ASHA).

If you have an active sore or blister you think may be herpes, see a clinician promptly — swabbing an active lesion is far more informative than waiting to time a blood test.

Why testing too early causes false negatives

A false negative during the window period is not a lab error. It is the expected behavior of the test given how it works:

• Antibody tests look for your immune system's response. It takes time — often weeks — to produce enough antibodies to be measurable.
• Antigen tests look for proteins the pathogen produces. Levels may be low in the earliest days after infection.
• NAATs look for the pathogen's genetic material. They are the earliest to turn positive but still require the organism to have replicated enough to be detectable, and they are not available for every infection.

Testing before the window closes can offer false reassurance. A negative result at day 3 after a chlamydia exposure, for example, tells you very little (per CDC). Waiting until the window closes — or retesting after it does — is what makes the result trustworthy.

When you should consider testing after a possible exposure

Timing depends on what you were exposed to and whether you have symptoms. General guidance drawn from the CDC and USPSTF:

• No symptoms, single possible exposure to common bacterial STIs (chlamydia, gonorrhea, trichomoniasis): many clinicians recommend testing around 2 weeks after exposure to give the window time to close (per CDC).
• Blood-borne infections (HIV, syphilis, hepatitis B, hepatitis C): initial testing is often reasonable at 3 to 6 weeks with a follow-up test at 3 months for HIV and hepatitis C (per CDC).
• Any symptoms at any time: see a clinician — do not wait for a window period.
• Routine screening without a specific exposure: the USPSTF recommends periodic screening for chlamydia and gonorrhea in sexually active people at increased risk and HIV screening at least once for adolescents and adults ages 15 to 65 (per USPSTF).

For a step-by-step guide to decisions in the first 72 hours after a possible exposure — including when PEP or emergency contraception may be relevant — see what to do after unprotected sex.

When repeat testing is recommended

A single negative test is not always the end of the story. Repeat testing is commonly recommended in these situations (per CDC):

• HIV: repeat at three months after a high-risk exposure if the initial test was a fourth-generation Ag/Ab test, or sooner if a NAT was used.
• Hepatitis C: repeat at six months if the initial antibody test was negative and exposure risk was significant.
• Syphilis: repeat at six weeks and three months if the initial test was early and the exposure risk was significant.
• After treatment for chlamydia, gonorrhea, or trichomoniasis: the CDC recommends a "test of reinfection" about three months after treatment because reinfection from an untreated partner is common (per CDC). This is not a test of cure — it is a test to see whether reinfection has occurred.
• New partners or ongoing exposure: if the exposure risk did not stop with a single event, periodic retesting on a schedule your clinician recommends is more informative than one-off tests.

Cost is not a reason to delay a recommended retest. Panels are available without insurance at Labcorp locations — see STD testing cost without insurance for a plain-English breakdown of what to expect.

What to do if symptoms appear before the window closes

Symptoms change the plan. If you develop any of the following before the window period is complete, do not wait — see a clinician (per CDC and Mayo Clinic):

• New sores, ulcers, or blisters in the genital, anal, or oral area
• Unusual discharge from the penis, vagina, or rectum
• Burning or pain with urination
• Pelvic or testicular pain
• Unexplained rash, especially on the palms or soles (which can be a symptom of secondary syphilis)
• Fever, swollen lymph nodes, or flu-like symptoms after a known high-risk exposure (which can be a symptom of acute HIV)

A clinician may order tests earlier than the standard window because certain tests (like a NAAT on a swab of a lesion, or an HIV NAT) can detect infection sooner than the antibody-based versions. This is a clinical judgment, not a self-directed decision.

How window periods should shape which panel you choose

Timing and panel choice go together. Two things to think about:

1. When you test relative to exposure. If you test before the window period closes for the infection you're most worried about, a negative result may need to be repeated. Scheduling the test at the point when the most windows have closed — often around 2 weeks for bacterial STIs and 3 to 6 weeks for blood-borne infections — usually gives you the most useful single snapshot (per CDC). A high-risk exposure may still warrant a three-month follow-up for HIV and hepatitis C.

2. Which infections the panel actually covers. Not every panel tests for every infection. Our Standard STI panel covers 6 key infections at Labcorp: HIV, syphilis, hepatitis B, hepatitis C, gonorrhea, and chlamydia. The Comprehensive Sexual Health Panel adds HSV-1, HSV-2, and Trichomoniasis, for 9 tests total. (Hepatitis A is not included in either panel.) For a side-by-side breakdown of what each panel covers, see our full STI panel guide.

Which one fits depends on your exposure history and what you want to rule in or out. If HSV serology or trichomoniasis matters for your situation, the comprehensive panel is the one to choose. If not, the standard panel covers the highest-yield infections.

<div class="my-8 rounded-2xl border border-primary/20 bg-primary/5 p-6"> <h3 class="mt-0 text-xl font-semibold">Ready to test at the right time?</h3> <p class="mt-2">Order a private, lab-drawn STI panel at Labcorp. Standard 6-test panel or Comprehensive 9-test panel, which adds HSV-1, HSV-2, and Trichomoniasis.</p> <p class="mt-4"><a href="/private-sti-panel" class="inline-flex items-center rounded-lg bg-accent px-5 py-3 font-semibold text-accent-foreground">See panels →</a></p> </div>

FAQ

Can I trust a negative test taken during the window period? Not fully. A negative result during the window period means the test could not yet detect the infection — it does not mean the infection is not there. Retesting after the window closes is what makes a negative result reliable for that specific test and exposure (per CDC).

How long should I wait to test after a possible exposure? It depends on the infection. For chlamydia, gonorrhea, and trichomoniasis, roughly 2 weeks is commonly cited. For HIV using a fourth-generation Ag/Ab test, about 18 to 45 days, with a three-month follow-up if risk was high. For syphilis and hepatitis, about 3 to 6 weeks (per CDC). If you have symptoms, do not wait — see a clinician.

Is a window period the same as an incubation period? No. The incubation period is the time until symptoms may appear; the window period is the time until a test can detect the infection (per Cleveland Clinic and CDC). They often do not match.

If I already have symptoms, do I still need to wait for the window period? No. Symptoms change the approach. A clinician may use a different test (for example, a NAAT on a swab of a lesion) that can detect infection earlier than the standard antibody test (per CDC). See a clinician rather than waiting.

Why do herpes blood tests get treated differently? Because HSV antibody blood tests have accuracy limitations and a meaningful false-positive rate, the CDC does not recommend routine HSV serologic screening in the general asymptomatic population (per CDC). For active symptoms, swabbing the lesion with a NAAT is more informative than a blood test.

Do I need to retest after treatment? Sometimes. The CDC recommends a "test of reinfection" about three months after treatment for chlamydia, gonorrhea, or trichomoniasis because reinfection from an untreated partner is common (per CDC). Your clinician will tell you what applies to your situation.

If my initial test is negative but my partner tested positive, should I still retest? Yes, likely. A negative test during the window period is not a rule-out. Talk to a clinician about when to retest based on the specific infection and exposure timing (per CDC).

Sources

• Centers for Disease Control and Prevention — Sexually Transmitted Infections Treatment Guidelines, 2021
• Centers for Disease Control and Prevention — HIV Testing Overview
• Centers for Disease Control and Prevention — Chlamydia — CDC Detailed Fact Sheet
• Centers for Disease Control and Prevention — Gonorrhea — CDC Detailed Fact Sheet
• Centers for Disease Control and Prevention — Syphilis — CDC Detailed Fact Sheet
• Centers for Disease Control and Prevention — Trichomoniasis — CDC Detailed Fact Sheet
• Centers for Disease Control and Prevention — Hepatitis B Testing
• Centers for Disease Control and Prevention — Hepatitis C Testing
• Centers for Disease Control and Prevention — Genital Herpes — CDC Detailed Fact Sheet
• American Sexual Health Association — STIs / STDs Overview
• U.S. Preventive Services Task Force — Screening for Chlamydia and Gonorrhea
• U.S. Preventive Services Task Force — HIV Screening in Adolescents and Adults
• MedlinePlus — STD Tests
• Cleveland Clinic — Sexually Transmitted Infections (STIs)
• Mayo Clinic — STD Symptoms

Educational content reviewed against CDC, ASHA, USPSTF, MedlinePlus, Cleveland Clinic, and Mayo Clinic guidance. Not a substitute for individualized medical advice, diagnosis, or treatment. If you have symptoms or a known exposure to a specific infection, contact a clinician.